Digital therapy for managing COPD
Official title: Digital Therapy in Self-management of Chronic Obstructive Pulmonary Disease Patients:A Prospective, Open-labled, Multicenter Randomized Controlled Clinical Study.
Run by China-Japan Friendship Hospital · NCT06776601 · Data updated 2026-11-12
This study tests a digital therapy program designed to help people with COPD use their inhalers correctly and stick to their medication to see if it can reduce flare-ups and improve their health.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 40 Years and up |
| Sex | All |
| Enrollment | 600 (estimated) |
| Sponsor | China-Japan Friendship Hospital Academic / other |
| Locations | 1 site (Beijing, Beijing Municipality) |
| Status | Recruiting |
| Started | July 18, 2024 |
| Main results expected | September 18, 2025 |
| Study ends | December 30, 2025 |
| Registry record updated | January 15, 2025 |
| Trial ID | NCT06776601 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients aged 40 and above with a diagnosis of COPD who have experienced severe exacerbations in the past year but are currently stable.
✕Probably not a fit
Patients with unstable comorbidities or recent surgeries, as well as pregnant or lactating women, may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This project implements a comprehensive digital therapy intervention for patients with Chronic Obstructive Pulmonary Disease (COPD). It includes an inhalation technique assessment device, an electronic inhalant medication monitoring device, and digital software to help patients use their inhalers correctly. The intervention aims to enhance medication adherence, manage behavior data, and provide personalized reminders and feedback to patients. The goal is to reduce acute exacerbations of COPD and improve overall disease management.
Why it matters
Potential benefit: If successful, this intervention could significantly improve medication adherence and reduce the frequency of acute exacerbations in COPD patients.
How similar studies have gone: Other studies have shown promise in using digital interventions for chronic disease management, indicating potential success for this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Patients diagnosed with COPD 2. Aged 40 and above 3. Had one or more severe acute exacerbations in the past year, and be in stable condition for the last 4 weeks 4. Can operate a smartphone proficiently 5. Take inhalation medication suits for the inhalation monitoring device as treatment 6. Fully understand and be willing to sign the informed consent form Exclusion Criteria: 1. Certain comorbidities (e.g. unstable coronary complications) 2. Undergone thoracic, abdominal or ophthalmic surgery in recent 3 months 3. Pregnant or lactating women 4. ABS allergy history
Where it's running
-
China Japan Friendship Hospital
Beijing, Beijing Municipality, China Recruiting
Study contacts
- Principal investigator: Hongtao Niu, PhD — China Japan Friendshi Hospital
- Study coordinator: Hanna Wu, MD
- Email: wuhanna0506@163.com
- Phone: 86+15827502015
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Flutter therapy added to chest physiotherapy after CABG in COPD patients
This study tests whether adding Flutter therapy to standard chest physiotherapy helps post-CABG patients with mild-to-moderate COPD improve breathing more than chest physiotherapy alone.
-
TPB-based cadence exercise and breathing training for COPD patients
A TPB-based program tests whether breathing training, cadence-guided walking, or both can improve lung function, exercise capacity, and quality of life in adults with COPD.
-
See how dynamic chest X-rays relate to COPD patterns and progression risk
This study looks at existing dynamic chest radiography data to see if new imaging measurements can identify COPD patterns, gauge severity, and predict who may experience faster progression.
-
Personalized mobile app warnings to reduce COPD flares
A personalized mobile app tests whether providing temperature-related risk warnings and protective tips, in addition to usual COPD care, can lower COPD flare-ups over 12 months.
-
CLEAR model to predict when people with severe COPD can be taken off ventilatory support
This project will see if the CLEAR model can predict which adults with severe COPD on invasive or non‑invasive ventilation can be safely taken off ventilatory support.
-
Long-term safety of Tozorakimab in COPD patients with prior exacerbations
This study tests two long-term dosing regimens of tozorakimab in people with COPD who have a history of flare-ups and who completed earlier studies.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.